Background
Methods
Participants
Phenotypic definitions
Single nucleotide polymorphism (SNP) selection
Genotyping
Data quality control and statistical analysis
Subjects, no. of any incidence (%)a | |||||||||
---|---|---|---|---|---|---|---|---|---|
Total | SAb |
P
| HDPc |
P
| SAPd |
P
| SMAe |
P
f
| |
Sex | |||||||||
Male | 441 | 213 (48) | .03 | 357 (81) | .33 | 192 (44) | .03 | 77 (18) | .33 |
Female | 472 | 194 (41) | 370 (78) | 172 (36) | 71 (15) | ||||
Sickle cell type | |||||||||
AS | 147 | 51 (35) | .01 | 112 (77) | .02 | 46 (31) | .03 | 13 (9) | .008 |
AA | 656 | 316 (48) | 547 (83) | 280 (43) | 122 (17) | ||||
SS | 25 | 13 (52) | 17 (68) | 12 (48) | 2 (8) | ||||
Anti-malarial use | |||||||||
Yes | 786 | 371 (47) | < .0001 | 661 (84) | < .0001 | 331 (42) | .0006 | 137 (17) | .01 |
No | 127 | 36 (28) | 66 (52) | 33 (26) | 11 (9) | ||||
Placental blood parasitaemia | |||||||||
Yes | 210 | 84 (40) | .05 | 161 (77) | .11 | 76 (36) | .09 | 35 (17) | .93 |
No | 481 | 232 (48) | 394 (82) | 207 (43) | 79 (16) | ||||
Maternal peripheral parasitaemia | |||||||||
Yes | 296 | 121 (41) | 0.1 | 230 (78) | .25 | 109 (37) | .17 | 57 (19) | .11 |
No | 598 | 279 (47) | 484 (81) | 249 (42) | 90 (15) | ||||
Birth weight < 2500 g or gestation age < 37 weeks | |||||||||
Yes | 82 | 35 (43) | .58 | 59 (72) | .03 | 31 (38) | .54 | 15 (18) | .58 |
No | 636 | 292 (46) | 522 (82) | 263 (41) | 101 (16) | ||||
Low birth weight (< 2500 g) | |||||||||
Yes | 71 | 29 (41) | .41 | 51 (72) | .05 | 25 (35) | .31 | 13 (18) | .61 |
No | 651 | 299 (46) | 532 (82) | 270 (41) | 104 (89) | ||||
Pre-term birth (< 37 weeks gestation) | |||||||||
Yes | 29 | 11 (38) | .44 | 18 (62) | .01 | 10 (35) | .51 | 3 (10) | .37 |
No | 846 | 382 (45) | 685 (81) | 343 (41) | 141 (17) |
Results
Characteristics of study participants
Genotyping
SNP rs# | Gene(s) | Alleles | SNP position | MAF* | Role | AA change |
---|---|---|---|---|---|---|
rs2243113 |
IL12A
| A/G | chr3:161188557 | 0.08 | Promoter | - |
rs582054 |
IL12A
| T/A | chr3:161192695 | 0.21 | Intron | - |
rs583911 |
IL12A
| A/G | chr3:161193084 | 0.11 | Intron | - |
rs2243128 |
IL12A
| G/A | chr3:161193205 | 0.17 | Intron | - |
rs2243138 |
IL12A
| A/T | chr3:161197044 | 0.47 | Downstream | - |
rs2243140 |
IL12A
| T/C | chr3:161197241 | 0.11 | Downstream | - |
rs2243143 |
IL12A
| A/G | chr3:161197496 | 0.45 | Downstream | - |
rs3212227 |
IL12B
| A/C | chr5:158675537 | 0.39 | 3' UTR | - |
rs3213119 |
IL12B
| C/A | chr5:158676366 | 0.00 | Coding exon | 298 V/F |
rs2195940 |
IL12B
| C/T | chr5:158676930 | 0.25 | Intron | - |
rs3213103 |
IL12B
| G/A | chr5:158679014 | 0.07 | Intron | - |
rs3213099 |
IL12B
| C/G | chr5:158680114 | 0.02 | Intron (boundary) | - |
rs919766 |
IL12B
| A/C | chr5:158680142 | 0.28 | Intron (boundary) | - |
rs2853694 |
IL12B
| T/G | chr5:158681666 | 0.17 | Intron | - |
rs3213096 |
IL12B
| C/T | chr5:158682907 | 0.00 | Coding exon | 33 V/I |
rs2569253 |
IL12B
| T/C | chr5:158683571 | 0.17 | Intron | - |
rs2569254 |
IL12B
| C/T | chr5:158683827 | 0.06 | Intron | - |
rs3746190 |
IL12RB1
| G/A | chr19:18031384 | 0.07 | 3' UTR | - |
rs383483 |
IL12RB1
| A/G | chr19:18032886 | 0.44 | Intron (boundary) | - |
rs438421 |
IL12RB1
| C/T | chr19:18037086 | 0.30 | Intron | - |
rs2045386 |
IL12RB1
| G/A | chr19:18043266 | 0.28 | Intron | - |
rs447171 |
IL12RB1
| C/T | chr19:18045647 | 0.27 | Intron | - |
rs11575934 |
IL12RB1
| T/C | chr19:18047618 | 0.14 | Coding exon | 214 Q/R |
rs429774 |
IL12RB1
| T/C | chr19:18047752 | 0.24 | Intron (boundary) | - |
rs17882031 |
IL12RB1
| C/T | chr19:18048349 | 0.00 | Intron | - |
rs11575926 |
IL12RB1
| C/T | chr19:18049408 | 0.00 | Coding exon | 156 R/H |
rs11575925 |
IL12RB1
| G/C | chr19:18053977 | 0.00 | Coding exon | 74 S/R |
rs897751 |
IL12RB1
| A/G | chr19:18054349 | 0.30 | Intron | - |
rs439409 |
IL12RB1
| G/A | chr19:18054613 | 0.32 | Intron | - |
rs17884651 |
IL12RB1
| C/A | chr19:18058626 | 0.00 | Coding exon | 3 P/Q |
rs393548 |
IL12RB1
| T/A | chr19:18058744 | 0.27 | Promoter | -111 |
rs7544381 |
IL12RB2
| C/T | chr1:67546881 | 0.49 | Intron | - |
rs17129749 |
IL12RB2
| C/T | chr1:67552339 | 0.30 | Intron | - |
rs17129751 |
IL12RB2
| G/A | chr1:67552503 | 0.04 | Intron | - |
rs2307147 |
IL12RB2
| T/C | chr1:67559874 | 0.24 | Coding exon | 26 D/D |
rs17129778 |
IL12RB2
| A/T | chr1:67560279 | 0.12 | Intron | - |
rs17129792 |
IL12RB2
| G/A | chr1:67565087 | 0.04 | Coding exon | 149 R/Q |
rs1495963 |
IL12RB2
| C/T | chr1:67567907 | 0.32 | Coding exon | 238 S/S |
rs2307149 |
IL12RB2
| A/T | chr1:67568038 | 0.06 | Intron (boundary) | - |
rs17838054 |
IL12RB2
| G/A | chr1:67589869 | 0.00 | Intron | - |
rs2307145 |
IL12RB2
| G/C | chr1:67606115 | 0.11 | Coding exon | 426 Q/H |
rs2307153 |
IL12RB2
| G/A | chr1:67606231 | 0.004 | Coding exon | 465 G/D |
rs6685568 |
IL12RB2
| A/G | chr1:67627885 | 0.45 | Intron | - |
rs2270614 |
IL12RB2
| A/G | chr1:67628609 | 0.17 | Intron | - |
rs2229546 |
IL12RB2
| C/A | chr1:67634108 | 0.46 | Coding exon | 779 P/P |
rs17838066 |
IL12RB2
| T/G | chr1:67634194 | 0.00 | Coding exon | 808 L/R |
Association of gene polymorphisms in IL12 and its receptor with clinical phenotypes
Severe malaria anaemia episodes crude incidence/1000 person-months | Adjusted risk ratio (95% CI)
a
| |||||
---|---|---|---|---|---|---|
IL12 A-rs2243140b | TT | TC | CC | CC vs TT | TC vs TT |
P
|
12.2 | 7.7 | 0 | 0.28 (0.10-0.79) | 0.52 (0.31-0.89) | .006 | |
IL12RB1-rs429774c | TT | TC | CC | CC vs (TT+TC) |
P
| |
12.2 | 11.2 | 2.8 | 0.18 (0.05-0.69) | .00005 |
Crude incidence/1000 person-months | Adjusted risk ratio (95% CI)a | ||||
---|---|---|---|---|---|
IL12 A-rs2243138b | AA | AT | TT | TT vs (AA + AT) |
P
|
Severe anaemia episodes | 38.3 | 41.3 | 30.3 | 0.69 (0.53-0.89) | .004 |
Severe anemia with any parasitaemia episodes | 32.8 | 35.8 | 24.5 | 0.66 (0.49-0.89) | .004 |
IL12RB1-rs383483c | AA | AG | GG | AG vs (AA+GG) |
P
|
High-density parasitaemia episodes | 155.2 | 172.8 | 146.8 | 1.21 (1.07-1.36) | .003 |